Response to: 'Checkpoint inhibitors and arthritis: seeking balance between victories and defeats' by Moura and Moura

Affiliations

Comment

Thierry Schaeverbeke et al. Ann Rheum Dis. 2019 Sep.

. 2019 Sep;78(9):e92.

doi: 10.1136/annrheumdis-2018-213906. Epub 2018 Aug 12.

¹ Department of Rheumatology, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.

No abstract available

Keywords: autoimmune diseases; autoimmunity; corticosteroids; multidisciplinary team-care.

Conflict of interest statement

Competing interests: None declared.

Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer-clinical aspects and relationship with tumour response: a single-centre prospective cohort study.
Kostine M, Rouxel L, Barnetche T, Veillon R, Martin F, Dutriaux C, Dousset L, Pham-Ledard A, Prey S, Beylot-Barry M, Daste A, Gross-Goupil M, Lallier J, Ravaud A, Forcade E, Bannwarth B, Truchetet ME, Richez C, Mehsen N, Schaeverbeke T; FHU ACRONIM. Kostine M, et al. Ann Rheum Dis. 2018 Mar;77(3):393-398. doi: 10.1136/annrheumdis-2017-212257. Epub 2017 Nov 16. Ann Rheum Dis. 2018. PMID: 29146737
Checkpoint inhibitors and arthritis: seeking balance between victories and defeats.
Moura CA, Moura CG. Moura CA, et al. Ann Rheum Dis. 2019 Sep;78(9):e91. doi: 10.1136/annrheumdis-2018-213866. Epub 2018 Jun 27. Ann Rheum Dis. 2019. PMID: 29950326 No abstract available.